Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
β-glucan–recognizing pattern recognition receptors (PRRs) are a diverse set of immune receptors that identify β-glucans, which are essential carbohydrate components of fungal cell walls and certain plants (Brown GD, Nat Rev Immunol 2006). While Dectin-1 (CLEC7A) is the most prominent member of this group, other receptors such as Complement Receptor 3 (CR3/CD11b-CD18), Lactosylceramide (LacCer), and Scavenger Receptors (e.g., SCARF1, CD36) also play vital roles in sensing these polysaccharides (Ross GD, J Immunol 1985; Sato T, J Biol Chem 2006). These receptors are predominantly expressed on innate immune cells, including macrophages, neutrophils, and natural killer cells, where they initiate signaling cascades that lead to phagocytosis, respiratory burst, and the secretion of pro-inflammatory cytokines. In clinical development, these receptors are targeted by β-glucan-derived compounds like Imprime PGG to enhance the host's anti-tumor or anti-fungal immune responses (Goodridge HS, Immunol Rev 2009). For example, β-glucans can prime CR3 on neutrophils to kill tumor cells coated with complement-fixing antibodies. However, the therapeutic use of these pathways is complicated by the structural diversity of β-glucans and the overlapping functions of the various receptors involved. Understanding the specific contributions of these "other" receptors, such as EphA2 in fungal recognition, is crucial for the design of next-generation immunomodulators (Swidergall M, PLoS Pathog 2018).
Agonism of innate immune receptors to enhance phagocytosis, oxidative burst, and cytokine production via Syk or Raf-1 signaling pathways.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Other β-glucan–recognizing pattern recognition receptors.